← FDA DRUG APPROVALS

FDA ANDA · ANDA205517

LINEZOLID

Sponsor: ALKEM LABS LTD

APPLICATION
ANDA205517
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-21
LATEST ACTION
2025-01-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

LINEZOLIDPrescription
LINEZOLID 600MG · TABLET · ORAL

Approval history

2025-01-16Labeling · Supplement 14 · standardAP
2024-04-05Labeling · Supplement 13 · standardAP
2024-04-05Labeling · Supplement 9 · standardAP
2024-04-05Labeling · Supplement 7 · standardAP
2022-02-23Labeling · Supplement 4 · standardAP
2018-12-31Labeling · Supplement 1 · standardAP
2015-12-21UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →